- Vendor: Mia Karts
Acute Myelogenous Leukemia: Genetics, Biology and Therapy (Cancer Treatment and Research, 145)
Free U.S. shipping on all orders. Free international shipping on orders over $99
All orders are dispatched the next business day!
Competitive Pricing You Can Trust — Quality You Can Rely On.
ISBN: 0387692576
Author: Nagarajan, Lalitha
Condition: New
Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unfold. Additional research in this area has helped identify key components and characteristics. Consequently, targeted therapy of AML is receiving much attention. It is the hope of researchers that as with chronic myelogenous leukemia (CML), and the drug, Gleevec, a targeted therapy for AML will be discovered.
Have a question?
Acute Myelogenous Leukemia: Genetics, Biology and Therapy (Cancer Treatment and Research, 145)